Applied DNA Stock News

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in cell-free, enzymatic DNA production, today anno

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA to participate in fireside chat at 34th Annual ROTH Investor Conference.

The shares of life sciences company, Applied DNA Sciences <> are rising on Wednesday amid reports that the U.S

Applied DNA Sciences, Inc. (NASDAQ: APDN ) a polymerase chain reaction based DNA manufacturer , closed its previously announced registered direct offering with an institutional investor of 1.5 million shares of common stock at a price of $2.80 per share for gross proceeds of approximately $4.2 million , before deducting the placement agent’s fees and other offering expenses payable by the company. In a concurrent private placement, Applied DNA also issued to the institutional investor in the offering unregistered … Full story available on Benzinga.com

Applied DNA Sciences (APDN) has dropped -12.80% pre-market after pricing its share offering.The company entered into a securities purchase agreement with an institutional investor for

ATGE, ALGN, and APDN have been added to the Zacks Rank #5 (Strong Sell) List on February 15, 2022

ATGE, ALGN, and APDN have been added to the Zacks Rank #5 (Strong Sell) List on February 15, 2022

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -231.58% and 2.62%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stoc

Applied DNA Sciences press release (APDN): Q1 GAAP EPS of -$0.63.Revenue of $4.17M (+157.4% Y/Y).Shares -1%.

Applied DNA Sciences, Inc.'s (APDN) CEO James Hayward on Q1 2022 Results - Earnings Call Transcript

Applied DNA Sciences (NASDAQ:APDN) is scheduled to announce Q1 earnings results on Thursday, February 10th, after market close.The consensus EPS Estimate is -$0.18 (+79.5% Y/Y) and…

Napco (NSSC) delivered earnings and revenue surprises of -66.67% and 6.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?